December 18, 2017

Kasten/DAKOTA Life Sciences Acquires Commercial Rights to Powerful Prescription Drug, Drug Delivery and Prescription Drug Protection Technologies

SIOUX FALLS, South Dakota, December 18, 2017 Kasten Inc. (OTC:KAST) d/b/a DAKOTA Life Sciences […]
March 7, 2017

Kasten, Inc. Completes Merger With Dakota Life Sciences

Kasten, Inc. (OTC PINK: KAST) announced today that it has completed a merger with […]
January 19, 2017

Kasten, Inc. Provides Shareholder Update on Status of Projects

Kasten, Inc. (OTC PINK: KAST) updated its shareholders today on the status of its […]
January 3, 2017

Kasten, Inc. Announces Signed Joint Venture Agreement with Dakota Life Sciences

SILVER SPRINGS, NV / ACCESSWIRE / January 3, 2017 / Kasten, Inc. (OTC PINK: […]
November 14, 2016

Kasten, Inc. Announces Agreement for Sublicensing of Novel Formulation of Bactracin for Drug Resistant Bacteria

Company provides information regarding a Sublicensing Agreement for Novel Formulations of Bactracin for the […]
November 10, 2016

Kasten, Inc. Announces Shareholder Update on Company Direction

Kasten, Inc. (OTC PINK: KAST) announces an update to shareholders on a new company […]
Contact Us